Pediatrix Medical Group, Inc. (MD) Guidance & Earnings Results
On 2026-07-15 Pediatrix Medical Group, Inc. reaffirmed guidance: "Adjusted EBITDA…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDPediatrix Medical Group, Inc.Follow MD — free
—
Price chart with a free account
- Market cap
- 2.4B
- P/E TTM
- 14.0
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 15 Jul 26 | Reaffirmed | Adjusted EBITDA $280M-$300M · full year |
| 19 Feb 26 | Raised | Revised upward expectations |
| 3 Nov 25 | Raised | Full year 2025 Adjusted EBITDA likely range between $270 million and $290 million · full year |
| 5 Aug 25 | Raised | FY2025 Adjusted EBITDA raised to $245-255M from $220-240M · full year |
Pediatrix Medical Group, Inc. — questions
- What guidance did Pediatrix Medical Group, Inc. give?
- On 2026-07-15: "Adjusted EBITDA $280M-$300M"
- When does Pediatrix Medical Group, Inc. report earnings?
- Pediatrix Medical Group, Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from Pediatrix Medical Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.